Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Gene therapy consists of the transfer of genetic material to cells to achieve a therapeutic goal. In the field of gastroenterology and hepatology gene therapy has produced considerable expectation as a potential tool in the management of conditions that lack effective therapy including non-resectable neoplasms of the liver, pancreas and gastrointestinal tract, chronic viral hepatitis unresponsive to interferon therapy, liver cirrhosis, and inflammatory bowel disease.

Original publication

DOI

10.1136/gut.52.suppl_2.ii49

Type

Journal article

Journal

Gut

Publication Date

05/2003

Volume

52 Suppl 2

Pages

ii49 - ii54

Addresses

Division of Hepatology and Gene Therapy, Department of Medicine, Clinica Universitaria, University of Navarra, Pamplona, Spain. jprieto@unav.es

Keywords

Animals, Humans, Hepatitis, Viral, Human, Digestive System Neoplasms, Gastrointestinal Diseases, Inflammatory Bowel Diseases, Liver Diseases, Chronic Disease, Genetic Therapy